Question 1
At what age should mammography screening begin for average-risk patients?
Correct Answer:
No later than 40
Explanation:
Beginning screening by age 40 for average-risk patients reflects the balance of detecting cancers at a smaller, more treatable stage while avoiding unnecessary testing too early for most women. The idea is that starting by age 40 ensures cancers that develop in the ensuing years can be found earlier, which can improve outcomes. Waiting until age 50 or 60 would delay detection for many cancers that arise in the 40s and early 50s, reducing the potential mortality benefit and allowing tumors to grow larger before discovery. For average-risk individuals—without a strong family history or other high-risk factors—this earlier start is the standard approach in many exam contexts, with proper screening intervals determined by guidelines and shared decision-making.
Question 2
Which term refers to the first menstrual period?
Correct Answer:
Menarche
Explanation:
Menarche is the term for the first menstrual period. It marks the onset of menstruation and puberty, as the body’s hormonal axis matures enough to trigger the first shedding of the endometrium. The timing varies widely, but it typically occurs in early adolescence. This concept is distinct from primary amenorrhea, which means menses have not begun by a certain age despite normal secondary sexual development; secondary amenorrhea refers to the loss of menses after they have previously started; and dysmenorrhea describes painful cramps during periods, not the first period itself.
Question 3
What is the typical folic acid dose for preconception and early pregnancy to reduce neural tube defects?
Correct Answer:
400-800 mcg
Explanation:
Folic acid helps the neural tube develop properly very early in pregnancy, often before a woman knows she’s pregnant. Because the tube closes by about 28 days after conception, starting supplementation preconception and continuing into early pregnancy reduces the risk of neural tube defects. The typical preventive dose is 400–800 micrograms per day, which can be taken as a vitamin supplement or as part of a fortified multivitamin. Zero intake obviously provides no protection, and 50 micrograms is below the standard preventive level. Four milligrams (4000 micrograms) daily is not the usual dose for most women; it’s reserved for those at high risk (such as a prior neural tube defect-affected pregnancy or certain medical conditions) where a higher dose may be indicated.
Question 4
Which tool collects both squamous and columnar cells in a single specimen?
Correct Answer:
The Cervical Broom
Explanation:
Collecting both squamous and columnar cells in one specimen is achieved by a device designed to sample from both the ectocervix and the endocervical canal in a single pass. The cervical broom does this by sweeping across the transformation zone, pulling in cells from both surfaces so the specimen contains mixed squamous and columnar cells. This is important because abnormalities can arise at the squamocolumnar junction, and having both cell types in one sample improves adequacy and detection. Other tools tend to target one area: a vaginal swab mainly collects vaginal squamous cells, a cytology brush focuses on endocervical cells, and an endocervical brush collects endocervical canal cells. None of these in a single pass combine both cell populations like the cervical broom does.
Question 5
Which palpation features are most characteristic of breast cancer?
Correct Answer:
Firm or hard, irregular, poorly delineated, possibly fixed, and non-tender
Explanation:
Palpation findings that raise concern for breast cancer include a mass that is firm or hard, with an irregular shape and poorly delineated margins, often fixed to surrounding tissues, and typically non-tender. This combination reflects malignant invasion and a desmoplastic reaction that makes the lump feel stony, irregular, and tethered to the chest wall or skin. The non-tender nature is common in cancer unless there is secondary inflammation. In contrast, a soft, mobile, well-delimited lump is more characteristic of benign lesions like a fibroadenoma or a simple cyst. A round, mobile, and tender lump can accompany benign inflammatory or cystic processes. A pulsatile and warm lesion points toward a vascular issue or infection/inflammation, not cancer.
Question 1
Exam overview

About this Exam

Prepare with the Women's Health History and Physical (H&P) Practice Exam practice quiz. This question bank includes 10 questions covering testing, mammography, begin, patients, and breast. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

Women's Health History and Physical (H&P) Practice Exam

This practice set contains 10 questions from the matching question bank and focuses on testing, mammography, begin, patients, and breast. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions